ArticleEuropean journal of neurology2025
Kappa Free Light Chain Index and Oligoclonal Bands in Varicella Zoster Virus Infection and Neuroborreliosis: A Matter of Timing?
Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Kappa Free Light Chain Index and Oligoclonal Bands in Varicella Zoster Virus Infection and Neuroborreliosis: A Matter of Timing?European journal of neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe diagnosis of Varicella-zoster virus related neurological disease (VZD) and Lyme neuroborreliosis (LNB) is based on clinical presentation as well as cerebrospinal fluid (CSF) results.
objectivesTo evaluate and compare the diagnostic utility of oligoclonal bands (OCB) and the κ-free light chain (FLC) index in patients with VZD and LNB.
methodsPatients with the diagnosis of VZD or LNB at the Department of Neurology of the Medical University of Innsbruck between 2008 to 2020 were included. OCB were determined by isoelectric focusing followed by immunoblotting, κ-FLC were measured by immunonephelometry.
resultsA total of 82 patients were included in the study comprising 48 patients with VZD and 34 with LNB. LNB patients exhibited higher κ-FLC indices (29 [14-45] vs. 4 [2-12], p < 0.001) and were more frequently OCB positive (65% vs. 8%, p < 0.001) than VZD patients. The disease duration was longer in OCB-positive patients (VZD: 21 [18-28] days; LNB: 15 [7-22] days) compared to OCB-negative patients (VZD: 10 [5-17] days, p = 0.030; LNB: 5 [4-7] days, p = 0.006). No differences in disease duration were observed between patients with positive or negative κ-FLC index. In multivariable analysis, OCB positivity was associated with disease duration (Odds Ratio [OR]: 1.11, 95% confidence interval: 1.01-1.23, p = 0.028), while κ-FLC index was not.
conclusionsIn both VZD and LNB, the κ-FLC index was more frequently positive than OCB, particularly in cases with shorter disease duration. This suggests that the κ-FLC index may be a more sensitive marker of (sub)acute intrathecal inflammation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.